... San Antonio Breast Cancer Symposium, held ... Monte Rosa Therapeutics is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health ...
News
- Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ... - BioSpace
... San Antonio Breast Cancer Symposium. December ... Celcuity is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health tablet ...
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...
... biotechnology company advancing therapies that ... The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer ...
- bioAffinity Technologies Set for Continued Expansion in 2025 | News | bakersfield.com
SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2024--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
- Ibrance combination extends median PFS in breast cancer group | The Pharmaletter
12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.